Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers
- Conditions
- InsulinemiaGlycaemia
- Interventions
- Other: Reference Glucose
- Registration Number
- NCT01870570
- Lead Sponsor
- Mondelēz International, Inc.
- Brief Summary
The purpose of this study is to determine and compare the glycaemic index values and response parameters of 6 food products between 3 laboratories.
- Detailed Description
This study will be performed at 3 centers and 15 subjects will be recruited at each center.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
-
Aged 18-35 years inclusive.
-
Non-smoker.
-
BMI 19.0-25.0 kg/m2 inclusive.
-
Healthy subjects with:
- Fasting plasma glucose < 5,6 mM (ADA criteria,2011)
- Insulin resistance index based on homeostasis model assessment (HOMA-IR) <1.70
- Fasting lipids: triglyceride <1.70mmol/L, LDL-cholesterol<5.00 mmol/L and HDL-cholesterol >1.03mmol/L for males or >1.29mmol/L for females (IDF criteria for metabolic syndrome, 2006)
- Gamma-GT, AST and ALT <1.5 times the upper limit of normal (ULN)
- Complete blood count: Normal full blood count according to the investigator
- Systolic blood pressure <130 mmHg
- Diastolic blood pressure <85 mmHg
- Resting heart rate 50-90 beats per minutes (after 3 minutes rest).
-
Stable dietary habits; normal eating patterns; no history of eating disorders or strict dieting.
-
Moderate level of physical activity (from basic daily activity to a high level of physical activity (regular physical activity at least 3 times per week))
-
Able to fast for at least 10 hours the night before each test session.
-
Able to refrain from eating legumes and drinking alcohol the day before each test session.
-
Subject covered by social security or covered by a similar system
-
Subject not taking any treatment for anorexia, weight loss, or any form of treatment likely to interfere with metabolism or dietary habits
-
Subject having given written consent to take part in the study
- Following a restrictive or specific diet.
- Suffering from any inflammatory or metabolic diseases
- Suffering from mental illness.
- Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc).
- Taking any regular prescription medication at the time of inclusion that should interfere with carbohydrate metabolism (except regular oral contraception medication, thyroid replacement therapy)
- Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive.
- Subject having taken part in another clinical trial within the last week.
- Subject currently taking part in another clinical trial or being in the exclusion period of another clinical trial.
- Subject undergoing general anaesthesia in the month prior to inclusion.
- Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Reference Glucose Reference Glucose Glucose Standard (50g of Glucose)
- Primary Outcome Measures
Name Time Method Determine and Perform Inter-Laboratory Comparison of Glycaemic Index Values of 6 Food Products 0-120 minutes
- Secondary Outcome Measures
Name Time Method Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products 0-120 minutes Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products 0-120 minutes Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products 0-120 minutes Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products 0-120 minutes Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products 01-20 minutes Determine the Intra-Laboratory Variability of the iAUC of Insulinemia 0-120 minutes Determination and Perform Inter-Laboratory Comparison of Insulin Cmax for Each of the 6 Food Products 0-120 minutes Determine and Perform Inter-Laboratory Comparison of the Blood Insulin Delta Peak for Each of the 6 Food Products 0-120 minutes Determine the Intra-Laboratory Variability for the iAUC of Glycaemia 0-120 minutes
Trial Locations
- Locations (3)
Human Nutrition Unit, The University of Sydney
🇦🇺Sydney, Australia
Glycemic Index Laboratories
🇨🇦Toronto, Ontario, Canada
Biofortis
🇫🇷Saint Herblain, France